The prognosis of patients treated with everolimus for advanced ER‐positive, HER2‐negative breast cancer is driven by molecular features

Abstract Everolimus is widely used in patients with advanced ER‐positive, HER2‐negative breast cancer. We looked at alterations in the PIK3CA/AKT/mTOR pathway in a multicenter cohort as potential biomarkers of efficacy. Patients with advanced ER‐positive, HER2‐negative breast cancer treated with eve...

Full description

Saved in:
Bibliographic Details
Main Authors: Hélène Salaün (Author), Lounes Djerroudi (Author), Laura Haik (Author), Anne Schnitzler (Author), Guillaume Bataillon (Author), Gabrielle Deniziaut (Author), Ivan Bièche (Author), Anne Vincent‐Salomon (Author), Marc Debled (Author), Paul Cottu (Author)
Format: Book
Published: Wiley, 2024-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available